InflaRx logo

InflaRx

Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory diseases

49 employees · est. 2007 · Jena, Germany

VS
Medix logo

Medix

Organic Immune-Boosting Innovations Nasal Inhaler & Atomizer

3 employees · est. 2019 · Miami Beach, United States

InflaRx is the older company (2007 vs 2019); InflaRx is the larger of the two.

Side-by-Side Comparison

InflaRx Medix
Founded
2007 older 2019
Headquarters
Jena, Germany Miami Beach, United States
Employees
49 larger 3
Industry
Health Care, Health and Wellness, Pharmaceutical Health Care, Manufacturing, Medical Devices
Funding Stage
Post Ipo Equity Not tracked yet
Total Funding
$250.20M Not tracked yet
Funding Rounds
9 Not tracked yet
Services
Development of anti-C5a and C5aR inhibitors, Clinical trials for inflammatory diseases, Research and development of transformative treatments, Commercialization of complement system inhibitors Not tracked yet
Target Customers
Hospitals treating COVID-19 patients, Healthcare providers, Pharmaceutical industries, Investors in biotechnology Not tracked yet
Taxonomy
Biopharmaceutical, Anti-Inflammatory Therapeutics, Anti-C5a Technology, Monoclonal Antibody Development, Chronic Inflammatory Diseases, Complement Activation Inhibitors, Vilobelimab, Oral Small Molecule Inhibitors, C5aR Technology, Acute Inflammation Treatment, Clinical Trials, Drug Discovery, Immunology Research, Complement System Modulation Immune-boosting, Nasal Inhaler, Atomizer, Patented Technology, Medical Device, Seed Round Funding, Anti-bacterial, Anti-viral, Anti-inflammatory, Start-up, Investment Opportunity, Innovation, Health Technology
Website
inflarx.de medixinhaler.com
InflaRx logo

About InflaRx

InflaRx, founded in 2007, is a Germany-based biopharmaceutical company recognized for pioneering anti-inflammatory therapeutics. The company's slogan, "Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory diseases," clearly reflects its mission. At the core...

Medix logo

About Medix

Medix is a startup that has developed a nasal inhaler and atomizer with the slogan "Organic Immune-Boosting Innovations." Their patented proprietary juice vial and inhaler design deliver proven ingredients, providing a more cost-effective product that is anti-bacterial, anti-microbial, anti-fungal,...

We will tell you when either one moves

BounceWatch watches InflaRx and Medix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at InflaRx and Medix — by email.

Frequently Asked Questions

InflaRx — Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory diseases. Medix — Organic Immune-Boosting Innovations Nasal Inhaler & Atomizer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
InflaRx has raised $250.20M while Medix has raised undisclosed funding.
InflaRx and Medix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare InflaRx with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at InflaRx on 14 May 2026, and Medix on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy